Cargando…
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
Laron syndrome (LS) is a rare genetic endocrinopathy that results from mutation of the growth hormone receptor (GH-R) gene and is typically associated with dwarfism and obesity. LS is the best characterized entity under the spectrum of the congenital insulin-like growth factor-1 (IGF1) deficiencies....
Autores principales: | Werner, Haim, Sarfstein, Rive, Nagaraj, Karthik, Laron, Zvi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696416/ https://www.ncbi.nlm.nih.gov/pubmed/33182502 http://dx.doi.org/10.3390/cells9112446 |
Ejemplares similares
-
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
por: Yaron-Saminsky, Danielle, et al.
Publicado: (2021) -
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
por: Werner, Haim, et al.
Publicado: (2019) -
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
por: Nagaraj, Karthik, et al.
Publicado: (2022) -
Insulin-like growth factors and aging: lessons from Laron syndrome
por: Werner, Haim, et al.
Publicado: (2023) -
The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer
por: Werner, Haim, et al.
Publicado: (2021)